A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain-Reference-Cited by-同舟云学术

A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

Published:2019-03 Issue:1 Volume:4 Page:62-72
ISSN:2378-8763
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Tyree Griffin A.¹,Sarkar Reith¹,Bellows Brandon K.²,Ellis Ronald J.³⁴⁵,Atkinson Joseph Hampton³⁴,Marcotte Thomas D.³⁴,Wallace Mark S.⁴⁶,Grant Igor³⁴,Shi Yuyan⁷,Murphy James D.⁸,Grelotti David J.³⁴

Affiliation:

1. School of Medicine, University of California San Diego, La Jolla, California.

2. Division of General Medicine, Columbia University, New York, New York.

3. Department of Psychiatry, University of California San Diego, La Jolla, California.

4. University of California Center for Medicinal Cannabis Research, San Diego, California.

5. Department of Neurosciences, University of California San Diego, La Jolla, California.

6. Department of Anesthesiology, University of California San Diego, La Jolla, California.

7. Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.

8. Department of Radiation Medicine and Applied Science, University of California San Diego, La Jolla, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2018.0027

Reference64 articles.

1. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

2. Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial

3. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

4. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

5. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Oral Cannabinoid-Rich THC:CBD Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting;2024

2. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023;Current Pain and Headache Reports;2023-12-14

3. Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence;Journal of Neurochemistry;2023-09-25

4. The Use of Cannabis for Pain Management;Cannabis Use in Medicine;2022

5. Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations;Value in Health;2021-10